2023 Form 5500 filing — Akros Pharma 401(K) Profit Sharing Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240625114959NAL0007267009001) for Akros Pharma 401(K) Profit Sharing Plan, reported by Akros Pharma, Inc. under EIN 94-3321539 and plan number 001. It reports 49 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$11.9MReported net assets$11,858,834
Participants49
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240625114959NAL0007267009001
Plan sponsor
Akros Pharma, Inc.
EIN
94-3321539
Plan number
001
Location
Princeton, NJ
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$11.9M total assets
Net assets$11.9MLiabilities$0
Money in vs. money out
Total income / additions$2.7M
Total expenses$43K
Benefits paid / distributions$43K
Contributions
Employer$265.7K
Participant$434.5K
Full reported line items
Total assets (EOY)
$11,858,834
Total liabilities (EOY)
$0
Net assets (EOY)
$11,858,834
Employer contributions
$265,658
Participant contributions
$434,490
Total income / additions
$2,748,561
Benefits paid
$42,990
Administrative expenses
$0
Total expenses
$42,990
Net increase / (decrease)
$2,705,571

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240625114959NAL0007267009001 cover?
It is the 2023 Form 5500 filing for Akros Pharma 401(K) Profit Sharing Plan, reported by Akros Pharma, Inc. (EIN 94-3321539).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages